PetMed Express Inc (PETS)

Currency in USD
3.280
+0.040(+1.23%)
Closed·
3.2800.000(0.00%)
·
PETS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.2303.300
52 wk Range
1.5705.580
Key Statistics
Prev. Close
3.24
Open
3.24
Day's Range
3.23-3.3
52 wk Range
1.57-5.58
Volume
70.55K
Average Volume (3m)
2.59M
1-Year Change
-34.2685%
Book Value / Share
2.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PETS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.750
Downside
-16.16%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

PetMed Express Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

PetMed Express Company Profile

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express Inc Earnings Call Summary for Q3/2025

  • PetMed Express Q4 2024: Net loss of $0.03/share, missing $0.01 loss forecast; revenue $53M, below $65M expected
  • Stock dropped 16.51% after-hours; company maintains strong balance sheet but unprofitable over last 12 months
  • Gross profit margin improved 80bps to 28.1%; adjusted EBITDA up to $2M from $900K despite 19% revenue decline
  • Focus on customer experience, SKU reduction, digital enhancements; targeting younger demographics and higher-income households
  • Analysts project sales decline but return to profitability; company expanding product portfolio with veterinary recommendations
Last Updated: 10/02/2025, 22:24
Read Full Transcript

Compare PETS to Peers and Sector

Metrics to compare
PETS
Peers
Sector
Relationship
P/E Ratio
−1.3x−8.3x11.1x
PEG Ratio
0.000.120.02
Price/Book
1.6x1.4x1.4x
Price / LTM Sales
0.4x0.2x1.0x
Upside (Analyst Target)
−15.1%92.0%22.9%
Fair Value Upside
Unlock19.2%10.6%Unlock

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Strong Sell

Analysts 12-Month Price Target:

Average 2.750
(-16.16% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Morgan Stanley
Sell2.75-16.16%3.00Maintain23/10/2025
Morgan Stanley
Sell3.00-8.54%3.20Maintain29/07/2025
Morgan Stanley
Sell3.20-2.44%3.50Maintain17/04/2025

Earnings

Latest Release
Dec 19, 2025
EPS / Forecast
-0.41 / 0.07
Revenue / Forecast
44.36M / 60.76M
EPS Revisions
Last 90 days

People Also Watch

1.6250
LGHL
+8.33%
0.9188
ADTX
-5.07%
1.95
BTTC
-7.58%
5.3200
WHLR
-0.56%
4.850
LONA
-9.51%

FAQ

What Is the PetMed Express (PETS) Share Price Today?

The live PetMed Express share price today is 3.280

What Stock Exchange Does PetMed Express (PETS) Trade On?

PetMed Express is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for PetMed Express?

The stock symbol (also called a 'ticker') for PetMed Express is "PETS."

What Is the Current PetMed Express Market Cap?

As of today, PetMed Express market capitalisation is 70.01M.

What Is PetMed Express's (PETS) Earnings Per Share (TTM)?

The PetMed Express EPS is currently -2.65 (Trailing Twelve Months).

When Is the Next PetMed Express Earnings Date?

PetMed Express's next earnings report will be released on 10 May 2026.

Is PETS a Buy or Sell From a Technical Analyst Perspective?

Based on today's PetMed Express moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has PetMed Express Stock Split?

PetMed Express has split 1 times. (See the PETS stock split history page for full effective split date and price information.)

How Many Employees Does PetMed Express Have?

PetMed Express has 173 employees.

What is the current trading status of PetMed Express (PETS)?

As of 29 Jan 2026, PetMed Express (PETS) is trading at a price of 3.280, with a previous close of 3.240. The stock has fluctuated within a day range of 3.230 to 3.300, while its 52-week range spans from 1.570 to 5.580.

What Is PetMed Express (PETS) Price Target According to Analysts?

The average 12-month price target for PetMed Express is USD2.750, with a high estimate of USD2.75 and a low estimate of USD2.75. 0 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Sell. The stock has an -16.16% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.